These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1670768)

  • 1. Expression of human IMP dehydrogenase types I and II in Escherichia coli and distribution in human normal lymphocytes and leukemic cell lines.
    Konno Y; Natsumeda Y; Nagai M; Yamaji Y; Ohno S; Suzuki K; Weber G
    J Biol Chem; 1991 Jan; 266(1):506-9. PubMed ID: 1670768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective up-regulation of type II inosine 5'-monophosphate dehydrogenase messenger RNA expression in human leukemias.
    Nagai M; Natsumeda Y; Konno Y; Hoffman R; Irino S; Weber G
    Cancer Res; 1991 Aug; 51(15):3886-90. PubMed ID: 1677309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two distinct cDNAs for human IMP dehydrogenase.
    Natsumeda Y; Ohno S; Kawasaki H; Konno Y; Weber G; Suzuki K
    J Biol Chem; 1990 Mar; 265(9):5292-5. PubMed ID: 1969416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of human type I and type II IMP dehydrogenases.
    Carr SF; Papp E; Wu JC; Natsumeda Y
    J Biol Chem; 1993 Dec; 268(36):27286-90. PubMed ID: 7903306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferation-linked regulation of type II IMP dehydrogenase gene in human normal lymphocytes and HL-60 leukemic cells.
    Nagai M; Natsumeda Y; Weber G
    Cancer Res; 1992 Jan; 52(2):258-61. PubMed ID: 1345808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective inhibition of human Molt-4 leukemia type II inosine 5'-monophosphate dehydrogenase by the 1,5-diazabicyclo[3.1.0]hexane-2,4-diones.
    Barnes BJ; Eakin AE; Izydore RA; Hall IH
    Biochemistry; 2000 Nov; 39(45):13641-50. PubMed ID: 11076502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme-pattern-targeted chemotherapy with tiazofurin and allopurinol in human leukemia.
    Weber G; Jayaram HN; Lapis E; Natsumeda Y; Yamada Y; Yamaji Y; Tricot GJ; Hoffman R
    Adv Enzyme Regul; 1988; 27():405-33. PubMed ID: 2907968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of human T lymphocyte activation on inosine monophosphate dehydrogenase expression.
    Dayton JS; Lindsten T; Thompson CB; Mitchell BS
    J Immunol; 1994 Feb; 152(3):984-91. PubMed ID: 7905505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human inosine monophosphate dehydrogenase type I and type II proteins. Purification and characterization of inhibitor binding.
    Hager PW; Collart FR; Huberman E; Mitchell BS
    Biochem Pharmacol; 1995 May; 49(9):1323-9. PubMed ID: 7763314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of inosine monophosphate dehydrogenase type I and type II isoforms in human lymphocytes.
    Jain J; Almquist SJ; Ford PJ; Shlyakhter D; Wang Y; Nimmesgern E; Germann UA
    Biochem Pharmacol; 2004 Feb; 67(4):767-76. PubMed ID: 14757177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inosine 5'-phosphate dehydrogenase activity in normal and leukemic blood cells.
    Becher HJ; Löhr GW
    Klin Wochenschr; 1979 Oct; 57(20):1109-15. PubMed ID: 292819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and characterization of inosine 5-monophosphate dehydrogenase in Streptococcus suis type 2.
    Zhang XH; He KW; Duan ZT; Zhou JM; Yu ZY; Ni YX; Lu CP
    Microb Pathog; 2009 Nov; 47(5):267-73. PubMed ID: 19744553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased inosine-5'-phosphate dehydrogenase gene expression in solid tumor tissues and tumor cell lines.
    Collart FR; Chubb CB; Mirkin BL; Huberman E
    Cancer Res; 1992 Oct; 52(20):5826-8. PubMed ID: 1356621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of mutant murine lymphoma cells with altered inosinate dehydrogenase activities.
    Ullman B
    J Biol Chem; 1983 Jan; 258(1):523-8. PubMed ID: 6129253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue-differential expression of two distinct genes for human IMP dehydrogenase (E.C.1.1.1.205).
    Senda M; Natsumeda Y
    Life Sci; 1994; 54(24):1917-26. PubMed ID: 7910933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and sequence of a cDNA encoding mouse IMP dehydrogenase.
    Tiedeman AA; Smith JM
    Gene; 1991 Jan; 97(2):289-93. PubMed ID: 1671845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene amplification and dual point mutations of mouse IMP dehydrogenase associated with cellular resistance to mycophenolic acid.
    Lightfoot T; Snyder FF
    Biochim Biophys Acta; 1994 Mar; 1217(2):156-62. PubMed ID: 7906545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inosine-5'-monophosphate dehydrogenase: regulation of expression and role in cellular proliferation and T lymphocyte activation.
    Zimmermann AG; Gu JJ; Laliberté J; Mitchell BS
    Prog Nucleic Acid Res Mol Biol; 1998; 61():181-209. PubMed ID: 9752721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tiazofurin down-regulates expression of c-Ki-ras oncogene in a leukemic patient.
    Weber G; Nagai M; Natsumeda Y; Eble JN; Jayaram HN; Paulik E; Zhen WN; Hoffman R; Tricot G
    Cancer Commun; 1991 Mar; 3(3):61-6. PubMed ID: 1705812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased activity, amount, and altered kinetic properties of IMP dehydrogenase from mycophenolic acid-resistant neuroblastoma cells.
    Hodges SD; Fung E; McKay DJ; Renaux BS; Snyder FF
    J Biol Chem; 1989 Oct; 264(30):18137-41. PubMed ID: 2572589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.